Finance News – Pharma
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Ceo
Investors
Shares
Tariffs
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Xrp
Stablecoin
Etf
Investment
Bse
Blockchain
Ipo
Sec
Eth
Index
Solana
Trade
Inflation
Earnings
Interest Rates
Coinbase
Revenue
Sensex
Token
Wall Street
Nasdaq
China
Federal Reserve
Nse
Treasury
Traders
Bse Sensex
Gold
Sp 500
Nifty
Tesla
Economy
Profit
Usd
Investor
Bonk
Asset Forfeiture
Sei Labs
Financial Technologies
Roxom Global
Venture Funds
Statistics Agency
Caseys General Stores
Evsales
Kddi
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jun 03, 2025
Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...
Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...
Read Full Article →
Quartz • May 30, 2025
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Despite its initial leadership in the growing weight loss medication sector, Novo Nordisk has recently experienced a decline in market share compared to Eli Lilly, affecting its fi...
Read Full Article →
Quartz • May 12, 2025
Eli Lilly stock sinks as pharma misses out on the market rally
Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...
Read Full Article →